Gavi, the Vaccine Alliance and partners set to reach 86 million adolescent girls with the human papillomavirus (HPV) vaccine by 2025, outlining an action plan following the Gavi Board’s approval of the revitalisation of the HPV programme. It is integral that governments urgently introduce the HPV vaccine if they haven’t done so. The COVID-19 pandemic also severely impacted HPV vaccination programmes, many of which are school-based, resulting in girls missing out on life-saving vaccines. Gavi and partners have been working with manufacturers for several years to support the development of a healthier HPV vaccine market. With the additional funding in place, the Alliance has set an ambitious goal to reach over 86 million girls by 2025, aiming to avert over 1.4 million future deaths from cervical cancer.

Source: News Business Ethiopia April 28, 2023 20:37 UTC